Surgery is riskier for people with diabetes than for those without it, but the word “dangerous” overstates the situation for most patients whose blood sugar is well managed. A large nationwide study found that diabetes roughly doubled the odds of dying within 30 days of a noncardiac operation, and the risks of kidney failure and heart attack after surgery were each about three and a half times higher than in non-diabetic patients.1PubMed Central. Adverse outcomes after noncardiac surgery in patients with diabetes Those numbers sound alarming in isolation, but the absolute event rates for most procedures remain low, and nearly every one of the extra risks tied to diabetes can be reduced with preparation. The real question is not whether surgery is safe for you, but what you and your surgical team need to do beforehand to close the gap.
How Much Higher Is the Risk, Really?
Diabetes touches almost every system that matters during and after an operation: the immune system, blood vessels, kidneys, and the heart. In that same nationwide cohort, patients with diabetes also stayed in the hospital longer and ran up about a third more in medical costs compared with matched non-diabetic patients.1PubMed Central. Adverse outcomes after noncardiac surgery in patients with diabetes For cardiac surgery specifically, raw mortality rates in one study were roughly twice as high in diabetic patients as in non-diabetic ones, though when researchers adjusted for other health conditions, diabetes alone stopped being a statistically significant driver of death.2Diabetes Care. Reduction of Surgical Mortality and Morbidity in Diabetic Patients Undergoing Cardiac Surgery With a Combined Intravenous and Subcutaneous Insulin Glucose Management Strategy That finding hints at something important: much of the danger comes not from diabetes as a label, but from the complications diabetes has already caused in your body. A person with well-controlled type 2 diabetes and no organ damage faces a very different set of odds than someone with kidney disease, nerve damage, and an HbA1c above 10%.
Why Your HbA1c Level Matters Before Surgery
If there is one number surgeons and anesthesiologists focus on during pre-surgical planning, it is your HbA1c, which reflects average blood sugar over the past two to three months. A meta-analysis pooling data from studies of major abdominal surgery found that patients with a high HbA1c had nearly three times the risk of anastomotic leaks (where a surgical join fails to heal), about double the rate of major complications, and a modestly higher rate of wound infections.3PubMed Central. The impact of preoperative glycated hemoglobin (HbA1c) on postoperative complications after elective major abdominal surgery: a meta-analysis A narrative review examining multiple surgical specialties concluded that an HbA1c below 8% is acceptable for most procedures, but that more demanding operations like spinal fusions, joint replacements, and heart surgery call for a tighter target of 7% or lower.4PubMed Central. A1C as a Prognosticator of Perioperative Complications of Diabetes: A Narrative Review
The practical takeaway is that if your surgery is elective, you may have time to bring your HbA1c down before the operation. Even a few months of tighter control can shift you into a lower-risk bracket. Emergency surgery, of course, does not give you that luxury, which is one reason emergency procedures carry higher complication rates for diabetic patients across the board.
What Surgery Does to Your Blood Sugar
Even people without diabetes can develop high blood sugar during an operation. The physical stress of surgery triggers a cascade of hormones that ramp up glucose production and make cells more resistant to insulin.5PubMed Central. Hyperglycemia in the Perioperative Period For someone with diabetes, this stress response stacks on top of an already impaired system. The result is that blood sugar can spike unpredictably during and after surgery. Perioperative hyperglycemia is linked to higher infection rates and higher mortality in both diabetic and non-diabetic patients.6PubMed Central. Hyperglycemia and perioperative glucose management On top of the high readings, swings in blood sugar (going from very high to suddenly low and back) carry their own independent risk, so the goal is not just to keep numbers below a threshold but to keep them relatively steady.
Hypoglycemia is the other side of the coin. When you are under general anesthesia, the typical warning signs of low blood sugar, like sweating, shaking, and confusion, are invisible to both you and the surgical team.7Rev. Bras. Anestesiol. Evaluation and perioperative management of patients with diabetes mellitus. A challenge for the anesthesiologist This is why frequent blood glucose checks during surgery are standard practice for diabetic patients.
Wound Healing and Infection
This is the complication most diabetic patients have heard of, and the evidence backs up the concern. Diabetes impairs wound healing at nearly every stage: it promotes excessive inflammation, reduces the growth of new blood vessels into the wound, and weakens the immune response at the surgical site. Diabetic patients face higher rates of wound infections, wound breakdown, and abnormal scarring.8PubMed Central. Updates in Diabetic Wound Healing, Inflammation, and Scarring A narrative review focused specifically on surgical site infections confirmed that the impaired immune response and microvascular damage caused by high blood sugar are central drivers of this elevated risk.9Journal of Health and Rehabilitation Research. Diabetes and Risk of Surgical Site Infection: A Narrative Review
The infection risk is not abstract. In a study of total hip replacements, diabetes was the only variable that significantly predicted surgical site infections.10PubMed Central. Clinical Implication of Diabetes Mellitus in Primary Total Hip Arthroplasty A meta-analysis of patients undergoing coronary artery bypass grafting found that diabetic patients had about twice the rate of both deep sternal wound infections and superficial wound infections compared with non-diabetic patients.11PubMed Central. Impact of diabetic versus non‐diabetic patients undergoing coronary artery bypass graft surgery on postoperative wound complications: A meta‐analysis Fortunately, as discussed below, tight glucose control during and after surgery can sharply reduce these rates.
Heart and Kidney Risks After Surgery
Cardiovascular events are a leading concern. A population-based cohort study found that within 30 days of noncardiac surgery, people with diagnosed diabetes had about 2.3 times the risk of a major adverse cardiac event compared with non-diabetic patients. Strikingly, even people with undiagnosed diabetes (detected through lab values rather than a prior diagnosis) showed a similarly elevated risk.12PubMed. Diabetes Status and Cardiovascular Complications Risk in Noncardiac Surgery: A Population-Based Cohort Study In vascular surgery patients, the increased risk was most pronounced among those requiring insulin; after adjusting for other health conditions, patients on insulin still had about a 50% higher risk of death or cardiovascular complications, whereas patients managed with oral medications alone did not carry a statistically significant extra risk.13Journal of Vascular Surgery. Impact of diabetes mellitus on perioperative outcomes and length of stay in patients undergoing major vascular surgery
The kidneys are another vulnerable target. Diabetes is already the leading cause of chronic kidney disease, and surgery places additional stress on the kidneys through blood loss, blood pressure shifts, and certain medications. In coronary artery bypass patients, diabetes was an independent risk factor for acute kidney injury regardless of how well the kidneys were working beforehand, with insulin-treated patients facing the highest severity.14PubMed Central. The impact of diabetes mellitus on acute kidney injury after coronary artery bypass grafting A separate study of cardiac surgery found that diabetic patients had a roughly five-fold risk of renal complications and a three-and-a-half-fold risk of neurological complications compared with non-diabetic patients undergoing the same bypass procedures.15PubMed. Diabetes and complications after cardiac surgery: comparison with a non-diabetic population
Type 1 Versus Type 2 Diabetes
Not all diabetes is the same in the operating room. In the nationwide noncardiac surgery cohort, type 1 diabetes carried a higher postoperative mortality risk than type 2. Patients with type 1 diabetes also showed elevated risk if they had existing complications like eye disease, circulatory problems, or a history of ketoacidosis or diabetic coma.16Diabetes Care. Adverse Outcomes After Noncardiac Surgery in Patients With Diabetes A study of spinal fusion surgery put numbers on the gap: within one year, patients with type 1 diabetes had an infection rate nearly three times that of type 2 patients, a reoperation rate about three times higher, and a readmission rate that was roughly four times greater.17Spine Open. Comparative Analysis of Postoperative Outcomes in Type 1 Versus Type 2 Diabetes Mellitus Patients Undergoing Spinal Fusion
Several factors explain this. Type 1 diabetes involves complete insulin deficiency, making blood sugar harder to stabilize under the hormonal storm of surgery. People with type 1 have often lived with diabetes longer, accumulating more vascular and nerve damage. And the risk of diabetic ketoacidosis, a metabolic emergency, is inherently higher in type 1 patients whose insulin supply is interrupted even briefly.
Autonomic Neuropathy and Anesthesia
One of the less well-known surgical risks for diabetic patients involves the nervous system. Diabetes can damage the autonomic nerves that control heart rate and blood pressure, a condition called cardiovascular autonomic neuropathy. Because anesthesia itself suppresses autonomic reflexes, the combination of neuropathy and anesthesia can produce unexpected drops in blood pressure or heart rate during the procedure.18PubMed. The impact of autonomic dysfunction on peri-operative cardiovascular complications In one study, about a third of diabetic patients needed blood-pressure-supporting drugs during anesthesia, compared with just 5% of non-diabetic controls. The diabetic patients who required these drugs scored worse on simple autonomic function tests done before surgery.19PubMed. Increased intraoperative cardiovascular morbidity in diabetics with autonomic neuropathy This suggests that screening for autonomic neuropathy before surgery could identify the patients most likely to become hemodynamically unstable under anesthesia.
Adjusting Diabetes Medications Before Surgery
Getting medication timing right is one of the most actionable steps in reducing surgical risk. Current guidance recommends that most common diabetes drugs, including metformin, GLP-1 receptor agonists, and DPP-4 inhibitors, can be continued up to and including the day of surgery. SGLT-2 inhibitors, however, should be stopped at least three days beforehand.20PubMed Central. Current practice in the perioperative management of patients with diabetes mellitus: a narrative review For patients on long-acting insulin, most guidelines call for reducing the dose by about 20 to 30% the day before and the day of surgery. Short-acting insulin that is normally taken with meals is generally withheld on the morning of surgery since you will not be eating.20PubMed Central. Current practice in the perioperative management of patients with diabetes mellitus: a narrative review
The SGLT-2 Inhibitor Problem
SGLT-2 inhibitors deserve their own discussion because they create a surgical risk that is easy to miss. These drugs, which work by causing the kidneys to excrete excess glucose in urine, can trigger a form of diabetic ketoacidosis where blood sugar looks normal or only mildly elevated. Because the blood sugar reading is not alarming, this “euglycemic” ketoacidosis can fly under the radar until the patient becomes seriously ill. A retrospective study found that stopping SGLT-2 inhibitors at least three days before surgery dramatically lowered the incidence of this complication.21PubMed Central. Factors and preventive strategies for perioperative euglycemic diabetic ketoacidosis in patients with type 2 diabetes receiving sodium-glucose cotransporter 2 inhibitors: a retrospective study A case series found that the incidence of euglycemic ketoacidosis was low overall but jumped more than six-fold in emergency procedures, where there was no opportunity to stop the drug in advance.22PubMed. Inpatient Perioperative Euglycemic Diabetic Ketoacidosis Due to Sodium-Glucose Cotransporter-2 Inhibitors
A larger study looking at a broader marker of ketone elevation found that even among patients who had stopped their SGLT-2 inhibitor, the rate of elevated ketone-related events was modestly higher than in control patients, especially during cardiac surgery.23JAMA Surgery. Postoperative Outcomes Among Sodium-Glucose Cotransporter 2 Inhibitor Users If you take one of these medications, make sure every member of your surgical team knows about it. This is not something to forget to mention during your pre-op visit.
How Tight Glucose Control During Surgery Reduces Complications
Some of the most encouraging research in this area shows that the risks associated with diabetes can be meaningfully shrunk by keeping blood sugar tightly controlled during and immediately after the operation. In diabetic patients undergoing cardiac surgery, switching from occasional insulin shots to a continuous intravenous insulin drip cut the rate of deep sternal wound infections from 2% down to 0.8%.24PubMed. Continuous intravenous insulin infusion reduces the incidence of deep sternal wound infection in diabetic patients after cardiac surgical procedures In lower-extremity bypass surgery, implementing a postoperative insulin protocol dropped wound infections from 11% to 4%, and among the diabetic subgroup specifically, infections went from 10% to zero.25Journal of Vascular Surgery. Use of a postoperative insulin protocol decreases wound infection in diabetics undergoing lower extremity bypass These are large, clinically meaningful reductions. They suggest that a hospital’s perioperative glucose-management protocol may matter as much as the patient’s diabetes diagnosis itself.
Interestingly, there is early evidence that SGLT-2 inhibitors, despite the ketoacidosis risk they introduce, may protect the kidneys during surgery. A matched study of type 2 diabetes patients found lower rates of postoperative acute kidney injury among those taking an SGLT-2 inhibitor compared with those on a different class of diabetes drug.26Kidney International Reports. The Protective Effects of SGLT-2 Inhibitors Against Postoperative Acute Kidney Injury in Type 2 Diabetes Balancing that potential benefit against the ketoacidosis risk is a conversation for your endocrinologist and surgeon to have together.
Continuous Glucose Monitors in the Operating Room
Traditionally, blood sugar during surgery is checked with periodic finger-stick or arterial blood draws. Continuous glucose monitors, small sensors worn on the skin that report a reading every few minutes, are starting to change that picture. A trial of colorectal cancer patients with type 2 diabetes found that those managed with continuous monitoring had lower average blood sugar on the first and third days after surgery, better wound healing at the surgical join, and shorter hospital stays compared with patients managed with conventional spot checks.27PubMed Central. Effects of continuous glucose monitoring in enhanced recovery after colorectal cancer patient surgery with type 2 diabetes An observational study in general surgery patients confirmed that continuous monitors worked reliably during operations and did not interfere with the surgical environment.28PubMed. Feasibility of intraoperative continuous glucose monitoring: An observational study in general surgery patients If you already wear a continuous monitor, ask your surgical team whether they plan to use it during and after the procedure. Not all hospitals have protocols for it yet, but the technology is ready.
Socioeconomic Factors and Preoperative Preparation
One dimension of surgical risk for diabetic patients that gets little attention is economic. A study of cardiac surgery patients found that HbA1c levels above 7% were significantly linked to lower socioeconomic position. Those same patients had higher postoperative infection rates and longer hospital stays.29PubMed. Elevated Hemoglobin A1c Is Associated With Lower Socioeconomic Position and Increased Postoperative Infections and Longer Hospital Stay After Cardiac Surgical Procedures The connection makes sense: affording medications, healthy food, and regular doctor visits all influence how well controlled your diabetes is by the time you need surgery. This means that the patients who face the highest surgical risk may also have the fewest resources to optimize their health beforehand. If your surgery is elective and you are struggling to afford your diabetes medications or supplies, it is worth asking your surgical team about resources, because bringing down your HbA1c even modestly before an operation can change your complication profile.
Specific Procedures Where Diabetes Matters Most
Not all surgeries carry the same diabetes-related risks. Joint replacements are a common concern because the implanted hardware creates a surface where infections can take hold. In a cohort of more than 20,000 hip and knee replacements, diabetes was associated with roughly a 55% higher risk of prosthetic joint infection, though that increase shrank when researchers accounted for body weight and other surgical factors.30PubMed. Diabetes mellitus, hyperglycemia, hemoglobin A1C and the risk of prosthetic joint infections in total hip and knee arthroplasty In cardiac surgery using both internal thoracic arteries for grafting, one group of patients stood out for extremely high risk: obese diabetic women had a deep sternal wound infection rate of roughly 21%, compared with about 2% for all other patients. Obese diabetic men, by contrast, did not show the same elevated risk.31PubMed. Toward zero: deep sternal wound infection after 1001 consecutive coronary artery bypass procedures using arterial grafts: implications for diabetic patients Findings like these underscore that surgical risk in diabetes is not one-size-fits-all. The type of procedure, your sex, your body weight, and the specific grafting technique all interact with your diabetes to shape the actual odds.
For cardiac bypass surgery in particular, the choice of graft and the approach to sternal closure can be tailored to diabetic patients. Using chlorhexidine-alcohol skin prep and being selective about using both internal thoracic arteries in high-risk subgroups are strategies that have driven deep wound infection rates toward zero in some centers.31PubMed. Toward zero: deep sternal wound infection after 1001 consecutive coronary artery bypass procedures using arterial grafts: implications for diabetic patients The lesson is that advances in surgical technique and perioperative care have been specifically engineered to address the vulnerabilities that diabetes creates. A surgeon experienced with diabetic patients will already be deploying these strategies. If you are not sure, ask.